Biotech start-up develops, offers for sale COVID-19 IgG test using ELISA protocol
ZTA Biotech, a Budapest-based biotech start-up, announced 6 January the breakthrough development of a COVID-19 antibody (IgG) test using the ELISA protocol – and is offering the intellectual property rights to licensees or a sole-rights purchaser.